Systemic and Central Inflammation in AD

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Alzheimer Disease
Interventions
DRUG

11C-ER176

ER176 is a PET tracer that binds to the 18 kDa translocator protein (TSPO), which is expressed by activated microglia and astrocytes and is therefore an index of brain inflammation.

Trial Locations (1)

77030

RECRUITING

Houston Methodist Research Institute, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER